Silverback Therapeutics, Inc.
Formulations of Benzazepine Conjugates and Uses Thereof
Last updated:
Abstract:
Aqueous formulations comprising conjugates that comprise a compound comprising benzazepine or a benzazepine-like structure conjugated to a polypeptide are provided, as well as methods of treatment using the aqueous formulations. Lyophilized compositions comprising the conjugates that comprise a compound comprising benzazepine or a benzazepine-like structure conjugated to a polypeptide are also provided.
Status:
Application
Type:
Utility
Filling date:
14 Aug 2020
Issue date:
18 Mar 2021